Trends · Daily since 18:00

Signal, by category.

Pivot the desk by domain — clinical AI, longevity, neurotech, policy, Portugal. Grouped by day, with the 18:00 daily read at the top of each.

  • Show briefing index
    1. 1.INVEST Digital Health Conference: D2C Diagnostics, GLP-1s, Wearables on Agenda
    2. 2.Opinion: AI will diminish, not enhance, physician autonomy
    • INVEST Digital Health Conference: D2C Diagnostics, GLP-1s, Wearables on Agenda

      MedCity News

      INVEST Digital Health Conference: D2C Diagnostics, GLP-1s, Wearables on Agenda

      "While consumer focus is key, the actual market impact will hinge on how digital health tools prove clinical efficacy and navigate reimbursement, not just D2C appeal. Unit economics for D2C diagnostics remain challenging without clear clinical pathways."

      Read source →
    • Opinion: AI will diminish, not enhance, physician autonomy

      STAT News – Health Tech

      Opinion: AI will diminish, not enhance, physician autonomy

      "The claim that AI inherently diminishes autonomy overlooks the critical design choices in implementation: tools built for clinical decision support differ fundamentally from those designed for workflow automation or administrative oversight, each with distinct impacts on physician agency."

      Read source →
  • Show briefing index
    1. 1.Dental AI startup Relu secures €1.51M from Dental Innovation Alliance for US expansion
    2. 2.Curative and Wondr Health Partner to Scale Digital Metabolic Health Interventions
    3. 3.UnityPoint Health leverages AI for administrative relief, clinician workload
    4. 4.Moderna's mRNA Flu Shot Secures FDA Approval
    5. 5.Medicare's ACCESS Program Faces Patient Awareness Gap Amidst AI Regulation Push
    6. 6.US Regulators Convene Closed-Door Clinical AI Meetings
    • Dental AI startup Relu secures €1.51M from Dental Innovation Alliance for US expansion

      EU-Startups

      Dental AI startup Relu secures €1.51M from Dental Innovation Alliance for US expansion

      "While the capital infusion aids market access, Relu's long-term success hinges on demonstrating clear unit economics improvements for dental labs and securing widespread clinical validation beyond initial adoption."

      Read source →
    • Curative and Wondr Health Partner to Scale Digital Metabolic Health Interventions

      MedCity News

      Curative and Wondr Health Partner to Scale Digital Metabolic Health Interventions

      "The payer-provider model for digital therapeutics in metabolic health hinges on clear ROI from reduced claims, a metric Wondr Health will need to evidence at scale to justify broad insurance integration."

      Read source →
    • UnityPoint Health leverages AI for administrative relief, clinician workload

      MedCity News

      UnityPoint Health leverages AI for administrative relief, clinician workload

      "While touted as clinician-centric, the unit economics of deploying multiple AI solutions across a large health system need rigorous validation against direct labor cost savings and measurable clinician burnout reduction."

      Read source →
    • Moderna's mRNA Flu Shot Secures FDA Approval

      BioPharma Dive

      Moderna's mRNA Flu Shot Secures FDA Approval

      "While a technical win for mRNA platforms, the commercial viability of an mRNA flu vaccine hinges on demonstrating superior efficacy or manufacturing agility over established, low-cost options, beyond just a novel mechanism."

      Read source →
    • Medicare's ACCESS Program Faces Patient Awareness Gap Amidst AI Regulation Push

      STAT News – Health Tech

      Medicare's ACCESS Program Faces Patient Awareness Gap Amidst AI Regulation Push

      "The efficacy of digital health interventions like ACCESS is crippled by poor patient outreach, illustrating a critical last-mile problem in value-based care delivery; regulators courting industry on AI is merely regulatory capture rebranded."

      Read source →
    • US Regulators Convene Closed-Door Clinical AI Meetings

      STAT News – Health Tech

      US Regulators Convene Closed-Door Clinical AI Meetings

      "Transparency concerns mount as regulators shape clinical AI policy away from public scrutiny, potentially prioritizing industry interests over patient safety or equitable access."

      Read source →

Adjacent

The people building all this show up in Lisbon & Porto — see the programme or reserve a seat.